DIAGNOSTIC RESEARCH PROGRAM SUCCESS PRA’s Planning and Innovation Reduce Costs PR A HEAL TH SCIEN CES CASE STUDYTHE FUTURE OF CLINICAL DEVELOPMENT. REGIONS STUDY DESCRIPTION Non-invasive screening for fetal aneuploidy: a new maternal plasma marker United States Western Europe PATIENT POPULATION 6,600 N o. OF CLINICAL SITES 37 STUDY DURATION MONTHS 30 PRIMARY ENDPOINT Develop a prenatal aneuploidy test PRA SERVICES Analysis & Reporting Clinical

Join for free to read